πŸ‡ΊπŸ‡Έ FDA
Patent

US 11207323

sGC stimulators

granted A61KA61K31/506A61K31/517

Quick answer

US patent 11207323 (sGC stimulators) held by Cyclerion Therapeutics, Inc. expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cyclerion Therapeutics, Inc.
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/506, A61K31/517, A61K31/519, A61K31/5377